Adverse effects of dopamine potentiation by long-term treatment with selegiline.

Abstract excerpt

A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatm...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anemia, Hemolytic, Congenital
• Share to Antiparkinson Agents
• Share to Basal Ganglia